Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5799322 | 0.94 | JAK2 (0.34) | CYP3A4KCNH2 | |
| SCHEMBL5467100 | 0.90 | KCNH2 (0.35) | KCNH2 | |
| SCHEMBL5465810 | 0.85 | KCNH2 (0.41) | KCNH2 | |
| SCHEMBL5460702 | 0.85 | JAK2 (0.38) | CYP3A4KCNH2 | |
| SCHEMBL5465200 | 0.84 | CYP3A4 (0.37) | CYP3A4KCNH2 | |
| SCHEMBL5462521 | 0.84 | KCNH2 (0.44) | CYP3A4KCNH2 | |
| SCHEMBL5459342 | 0.84 | KCNH2 (0.38) | CYP3A4KCNH2 | |
| SCHEMBL5461918 | 0.83 | KCNH2 (0.32) | KCNH2 | |
| SCHEMBL5472846 | 0.82 | KCNH2 (0.43) | KCNH2 | |
| SCHEMBL5453081 | 0.81 | KCNH2 (0.32) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070191333-A1 | Antibacterial agents | WARNER LAMBERT COMPANY LLC | 2007-08-16 | — | — | US | claimed |
| US-20070191333-A1 | Antibacterial agents | WARNER LAMBERT COMPANY LLC | 2007-08-16 | — | — | US | disclosed |
| US-20070191333-A1 | Antibacterial agents | WARNER LAMBERT COMPANY LLC | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191333-A1 | Antibacterial agents | MRPL21, RPN2, FBL | CYP3A4 815/4885KCNH2 2633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.